ClinicalTrials.Veeva

Menu

Flash Glucose Monitoring Study for Diabetes (FUTURE)

U

Universitaire Ziekenhuizen KU Leuven

Status

Completed

Conditions

Diabetes

Study type

Observational

Funder types

Other

Identifiers

NCT02898714
FUTURE-59342

Details and patient eligibility

About

On the first of July 2016, the Freestyle Libre Flash Glucose Monitor (FGM) will be reimbursed in Belgium by means of a new diabetes reimbursement program for adults. For children, the Freestyle Libre FGM is also reimbursed by means of a new reimbursement program from the first of August 2016 onwards. Making this the only way to receive the device in Belgium. To understand the impact of this new FGM on diabetes patients in UZ Leuven, OLVZ Aalst, and UZ Antwerp, we want to study the use of the device by our patients by means of an observational study where patients complete questionnaires at regular time points in the first year of usage and after 24 months Clinical data will be gathered during the routine clinical visits as part of the reimbursement program.

Enrollment

2,331 patients

Sex

All

Ages

4+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signed informed consent
  • >= 4 years
  • Using flash glucose monitoring

Exclusion criteria

  • Doesn't want to sign the informed consent
  • < 4 years
  • Not using flash glucose monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems